Selection of genetically modified hematopoietic cells, and development of universally tolerated reversibly immortalized cell lines for gene and cell therapy – METI-CEA
Philippe LEBOULCH (COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES - CENTRE DE FONTENAY-AUX-ROSES)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES - CENTRE DE FONTENAY-AUX-ROSES
Help of the ANR 800,000 euros
Beginning and duration of the scientific project: - 48 Months